Funding

EnteroBiotix

United Kingdom · Biotech · Healthtech

Develops full-spectrum microbiome therapeutics for gastrointestinal diseases including IBS

Visit enterobiotix.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B£19MScottish National Investment Bank — Role not disclosedThairm Bio — Role not disclosed

Investors

Scottish National Investment BankSeries BThairm BioSeries B

Coverage

May 4, 2026EnteroBiotix · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesenterobiotix.com ↗